BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Houston's Westside Surgical Hospital Acquires Mazor Robotics' Renaissance System


3/27/2013 6:48:14 AM

CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (MZOR.TA), a developer of innovative surgical robots and complementary products, today announced that Westside Surgical Hospital in Houston, Texas acquired its Renaissance™ system. The system will be used by the hospital’s renowned spinal surgeons, including Richard R.M. Francis, MD. This system marks the 7th Renaissance system in Texas and the 21st system in the U.S.

Westside Surgical Hospital is a multi-specialty physician-owned hospital located in the heart of Houston. The facility employs a wide suite of physicians to service patients and counts spine surgery as one of its primary specialties. Dr. Richard Francis has special expertise in spinal disc replacement surgery, scoliosis correction, and revision/reconstruction of the previously operated spine. He practices spinal medicine exclusively. In 2012, he was recognized by Mazor for successfully performing over 100 Renaissance Robotics spine surgeries.

”When I first saw the Renaissance at NASS 2011, I was immediately impressed,” said Dr. Francis. “After my due diligence, I am convinced that the Renaissance system’s exceptional accuracy and safety will enhance outcomes for my patients, particularly those with advanced deformities and severe scoliosis.”

“We are so pleased to be supplying a system to Westside Surgical Hospital - an advocate of the Renaissance technology in the Houston marketplace,” stated Ori Hadomi, Mazor’s CEO. “We expect the system to be used in at least eight cases during its initial installation period of two weeks. As a leading authority in spine medicine, we’re thrilled to work with Dr. Francis again, this time bringing Renaissance to the patients of Westside Surgical Hospital.”

“By partnering closely with the leaders of spinal robotic technology, we are equipping our surgeons with the right tools to provide the best possible outcomes,” shared Westside Surgical Hospital’s Board Chairman, Mustapha Kibirige, MD. “This investment is part of our promise to offer the safest and most accurate surgical solutions for our patients.”

Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.

About Mazor

Mazor Robotics (MZOR.TA) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 35,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, please visit www.mazorrobotics.com.

Contact:

U.S. Contacts:

EVC Group

Investors

Aimee Gordon, 212-850-6020

agordon@evcgroup.com

Robert Jones, 646-201-5447

bjones@evcgroup.com

or

Media

Amy Phillips, 412-327-9499

aphillips@evcgroup.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES